ArticleEvidence-based complementary and alternative medicine : eCAM2022

Simvastatin Inhibits Endometrial Cancer Malignant Behaviors by Suppressing RAS/Mitogen-Activated Protein Kinase (MAPK) Pathway-Mediated Reactive Oxygen Species (ROS) and Ferroptosis.

Dan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.